Home LiteratureArticle Details
PMID: 2767708 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Reversible injury of cultured rat oligodendrocytes by complement.

Immunology ·Vol. 67 ·No. 4 ·1989-08-00 ·Pages 441-6

Scolding NJ, Houston WA, Morgan BP, Campbell AK, Compston DA

Abstract

Rat oligodendrocytes are lysed on exposure to normal homologous serum as a result of classical pathway complement activation and attack in the absence of anti-myelin antibodies. The effect of non-lethal complement attack on oligodendrocytes in vitro was studied by exposing dissociated neonatal rat optic nerve cell cultures to low concentrations of complement alone and also in the presence of oligodendrocyte-specific monoclonal antibodies. Regardless of the mode of complement activation, non-lethal complement attack led to reversible cell injury, recovery following a transient rise in intracellular calcium and fall in ATP in the absence of membrane permeabilization to propidium iodide. A single episode of non-lethal injury had no effect on the ability of oligodendrocytes subsequently to express cell-specific antigens, but repeated episodes had a cumulative effect and ultimately resulted in cell death. Reversible and/or lytic complement-mediated oligodendrocyte injury has implications for the pathogenesis of human and experimental demyelinating diseases.

MeSH Terms
Adenosine Triphosphate/metabolism Animals Calcium/metabolism Cell Membrane Permeability Cells, Cultured Complement Activation Complement C9/physiology Cytotoxicity, Immunologic Neuroglia/immunology Oligodendroglia/immunology,metabolism Rats
Chemicals
Complement C9 Adenosine Triphosphate Calcium
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Scolding N J
Section of Neurology, University of Wales College of Medicine, Heath Park, Cardiff.
Houston W A
Morgan B P
Campbell A K
Compston D A
References (30)
30 references, click to expand
  1. Metabolism of phosphate and sulfate groups modifying the P0 protein of peripheral nervous system myelin.
    J Neurochem. 1987 Mar;48(3):883-7 PMID: 2433400
  2. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes.
    J Neurochem. 1987 Jan;48(1):271-8 PMID: 3025367
  3. Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations.
    J Neurol Sci. 1988 Jan;83(1):37-53 PMID: 3126271
  4. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes.
    J Biol Chem. 1988 May 25;263(15):7228-34 PMID: 2452821
  5. In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium.
    Clin Exp Immunol. 1988 Sep;73(3):467-72 PMID: 3208453
  6. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    J Neurol Sci. 1989 Feb;89(2-3):289-300 PMID: 2926453
  7. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
    J Neuroimmunol. 1989 May;22(3):169-76 PMID: 2649509
  8. Remyelination in the central nervous system and the peripheral nervous system.
    Adv Neurol. 1988;47:215-54 PMID: 3278518
  9. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations.
    J Neurochem. 1972 Mar;19(3):653-62 PMID: 4337916
  10. Kinetics of the firefly luciferase catalyzed reactions.
    Biochemistry. 1974 Feb 26;13(5):921-5 PMID: 4813372
  11. Extraction, partial purification and properties of obelin, the calcium-activated luminescent protein from the hydroid Obelia geniculata.
    Biochem J. 1974 Nov;143(2):411-8 PMID: 4156828
  12. Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore.
    Nature. 1977 Feb 24;265(5596):734-6 PMID: 16216
  13. The ninth component of human complement: purification and physicochemical characterization.
    J Immunol. 1980 Mar;124(3):1291-6 PMID: 6766971
  14. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside.
    Proc Natl Acad Sci U S A. 1982 Apr;79(8):2709-13 PMID: 7045870
  15. Calcium ion stimulated protein kinases in myelin.
    Prog Brain Res. 1982;56:125-44 PMID: 7163500
  16. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.
    Nature. 1983 Jun 2-8;303(5916):390-6 PMID: 6304520
  17. Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives.
    Proc Natl Acad Sci U S A. 1983 Nov;80(21):6647-51 PMID: 6415654
  18. Impulse conduction regulates myelin basic protein phosphorylation in rat optic nerve.
    J Neurochem. 1984 Jul;43(1):243-8 PMID: 6202844
  19. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody.
    J Neuroimmunol. 1984 Sep-Oct;6(6):387-96 PMID: 6207204
  20. Inositol trisphosphate, a novel second messenger in cellular signal transduction.
    Nature. 1984 Nov 22-28;312(5992):315-21 PMID: 6095092
  21. Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS.
    J Neurochem. 1985 Aug;45(2):581-8 PMID: 2409235
  22. Chemiluminescence as an analytical tool in cell biology and medicine.
    Methods Biochem Anal. 1985;31:317-416 PMID: 3894883
  23. The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium.
    Biochem J. 1985 Oct 1;231(1):205-8 PMID: 4062885
  24. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    J Immunol. 1986 Jun 15;136(12):4456-9 PMID: 3711661
  25. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    J Immunol. 1986 Jul 1;137(1):263-70 PMID: 3711667
  26. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores.
    Blood. 1986 Aug;68(2):556-61 PMID: 3730616
  27. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes.
    J Immunol. 1986 Aug 15;137(4):1286-93 PMID: 2426360
  28. Cerebrospinal fluid C9 in demyelinating disease.
    Neurology. 1986 Nov;36(11):1503-6 PMID: 3762967
  29. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.
    J Immunol. 1987 Jan 1;138(1):246-53 PMID: 3782799
  30. Calcium ions trigger the expansion in bistable myelin.
    Neurosci Lett. 1987 Jan 14;73(2):167-72 PMID: 3822248
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
0019-2805
Published
1989-08-00
Pages
441-6
Language
English
Region
England
NLM ID
0374672
PMCID
PMC1385311
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]